Cantor Fitzgerald issued their FY2025 earnings estimates for shares of CVRx in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn expects that the company will post ...

CVRx (NASDAQ:CVRX – Get Free Report) is expected to post its quarterly earnings results before the market opens on Thursday, ...

William Blair analyst Margaret Kaczor reiterated a Buy rating on CVRx (CVRX – Research Report) on January 18 and set a price target of $17.62.

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Craig-Hallum raised the firm’s price target on CVRx (CVRX) to $22 from $20 and keeps a Buy rating on the shares. CVRx posted a modest beat in ...

CVRx (CVRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fintel reports that on January 14, 2025, William Blair upgraded their outlook for CVRx (NasdaqGS:CVRX) from Market Perform to Outperform. Analyst Price Forecast Suggests 14.74% Upside As of ...

Buy CVRX near 14.22 target n/a stop loss @ 14.18. Details The technical summary data tells us to buy CVRX near 14.22, but there is no current upside target from the summary table. In this case we ...

MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced certain preliminary unaudited fourth quarter and full ...

Fourth quarter revenue expected to be $15.2 million to $15.3 million, representing growth of 35%Full year revenue expected to ...

A live audio webcast of the conference presentation will be available online at the investor relations page of the Company's website at ir.cvrx.com. About CVRx, Inc. CVRx is focused on the ...